SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-14-010272
Filing Date
2014-06-12
Accepted
2014-06-12 19:49:53
Documents
2
Period of Report
2014-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3/A - edgar.html 3/A  
1 FORM 3/A - edgar.xml 3/A 1798
2 POWER OF ATTORNEY friedmanpoa.txt EX-24.TXT 3385
  Complete submission text file 0001179110-14-010272.txt   6621
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENOPORT, INC. 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address
FRIEDMAN CATHY (Reporting) CIK: 0001411874 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-30319 | Film No.: 14908403